Hyperprolactinemia: Prevention, Diagnosis, and When to See a Doctor
Prolactin is best known as the hormone that drives breast milk production, but it affects far more than lactation. When levels stay too high — a condition called hyperprolactinemia — both men and women can experience low libido, fertility problems, and bone loss. In the fitness world it often comes up in connection with certain anabolic steroids and medications. Our editorial team explains how it is recognized and when professional help is needed.
What prolactin does
Prolactin is produced mainly by lactotroph cells in the anterior pituitary gland. Unlike most pituitary hormones, it is controlled primarily by inhibition: dopamine released from the hypothalamus constantly suppresses prolactin secretion. Anything that reduces dopamine's influence tends to let prolactin rise.
Besides stimulating milk production after childbirth, prolactin influences the reproductive axis. High levels suppress gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn lowers luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The downstream effect is reduced testosterone in men and disrupted ovulation in women.
Prolactin also plays roles in immune function, metabolism, and behavior. It rises naturally during sleep, after exercise, with stress, and after sexual activity, which is why a single elevated reading does not automatically mean disease.
Normal reference ranges vary by laboratory, but women typically have somewhat higher levels than men, and pregnancy causes a large physiological increase. Interpreting results always requires clinical context.
Causes of high prolactin
The causes of hyperprolactinemia fall into three broad groups: physiological, pharmacological, and pathological. Identifying which applies is the first task of any medical workup.
| Category | Examples |
|---|---|
| Physiological | Pregnancy, breastfeeding, sleep, intense exercise, stress, nipple stimulation |
| Medications | Antipsychotics (e.g., risperidone, haloperidol), metoclopramide, some antidepressants, opioids, verapamil |
| Pituitary disease | Prolactinoma (prolactin-secreting adenoma), other tumors compressing the pituitary stalk |
| Other medical conditions | Primary hypothyroidism, chronic kidney disease, liver cirrhosis, chest wall injury |
| Performance-enhancing drug use | Reported in association with certain 19-nortestosterone derivatives (e.g., nandrolone, trenbolone) and with elevated estrogen |
| Laboratory artifact | Macroprolactin — large, mostly inactive prolactin complexes |
Medications are among the most common causes. Antipsychotic drugs that block dopamine D2 receptors are the classic example. Anyone taking these medications should never stop them on their own; adjustments must be made by the prescribing physician.
In gym culture, elevated prolactin is frequently attributed to 19-nor anabolic steroids. The mechanisms are not fully characterized, and the clinical evidence is mostly limited to case reports and observational data. Estrogen itself stimulates prolactin secretion, so supraphysiological estradiol from aromatized androgens may also contribute.
Prolactinomas are the most common hormone-secreting pituitary tumors. They are almost always benign but can cause problems through hormone excess and, if large, by pressing on surrounding structures such as the optic nerves.
Symptoms in men and women
Symptoms reflect two processes: suppressed sex hormones and, in some cases, direct effects of a pituitary mass. The presentation differs considerably between sexes.
- Women: irregular or absent periods, infertility, milky nipple discharge (galactorrhea), vaginal dryness, reduced libido.
- Men: decreased libido, erectile dysfunction, reduced sperm count, breast tissue enlargement, rarely galactorrhea, fatigue and loss of muscle mass.
- Both sexes: reduced bone density over time, mood changes, and weight gain.
- Mass-related: persistent headaches, loss of peripheral vision, double vision.
Women often notice changes earlier because menstrual disturbances are hard to miss. Men may live with vague symptoms like low libido for years before seeking care, which is one reason prolactinomas in men are often larger at diagnosis.
Long-term untreated hyperprolactinemia causes low estrogen or testosterone, which can accelerate bone loss and increase fracture risk. This makes timely diagnosis important even when symptoms seem mild.
It is worth noting that some symptoms commonly blamed on prolactin in bodybuilding forums — such as "prolactin gyno" — overlap heavily with estrogen-related effects and should be evaluated properly rather than self-diagnosed.
How hyperprolactinemia is diagnosed
Diagnosis begins with a blood test. According to the Endocrine Society clinical practice guideline, a single measurement above the upper limit of normal, drawn without excessive venipuncture stress, is usually enough to confirm hyperprolactinemia — but a repeat test is often performed if the elevation is mild.
Once high prolactin is confirmed, the physician looks for secondary causes: a pregnancy test in women of reproductive age, thyroid function tests (TSH), kidney and liver function, and a careful medication history. Testing for macroprolactin may be recommended in people without symptoms.
If no obvious cause is found, a pituitary MRI with contrast is usually ordered to look for a prolactinoma or another lesion. Men will often also have testosterone, LH, and FSH measured, and visual field testing may be added if a large tumor is present.
An important laboratory pitfall is the "hook effect," in which extremely high prolactin levels produce a falsely low result in some assays. Clinicians may request serial dilution when a large pituitary tumor is seen but prolactin is only modestly elevated.
Treatment depends on the cause. Dopamine agonists such as cabergoline and bromocriptine are first-line therapy for prolactinomas, and their use, dosing, and monitoring are determined exclusively by an endocrinologist due to potential side effects, including rare heart valve concerns at high doses.
Prevention and when to see a doctor
Not all hyperprolactinemia can be prevented — prolactinomas, for example, are not caused by lifestyle factors. But several practical measures reduce the risk of avoidable elevations or help detect them early.
The most important preventive step for athletes is avoiding non-prescribed anabolic steroids and other hormonal drugs. Using them disrupts the entire hypothalamic-pituitary-gonadal axis, and prolactin problems are only one possible consequence. Self-treating with dopamine agonists obtained without prescription carries its own risks and is strongly discouraged.
If you take medications known to raise prolactin, ask your doctor whether periodic monitoring makes sense. Treating underlying conditions such as hypothyroidism often normalizes prolactin on its own.
See a doctor promptly if you notice irregular or missed periods without pregnancy, nipple discharge, persistent loss of libido or erectile dysfunction, unexplained infertility, or breast enlargement in men. Seek urgent care for sudden severe headache or vision changes, which can signal pituitary bleeding (apoplexy).
Conclusions of the editorial team
Hyperprolactinemia is common, usually treatable, and frequently caused by medications or benign pituitary tumors. Its effects on fertility, sexual function, and bone health make diagnosis worthwhile.
A proper workup — repeat testing, review of medications, thyroid and kidney checks, and MRI when needed — identifies the cause in most cases.
For athletes, the clearest prevention is avoiding unsupervised hormonal drugs and seeing a physician rather than self-diagnosing based on online forums.
For further reading, consider our articles on gynecomastia causes and evaluation, how anabolic steroids affect fertility, and what a male hormone panel includes.
References
- Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–288.
- Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65(2):265–273.
- Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6(3):168–175.
- Molitch ME. Drugs and prolactin. Pituitary. 2008;11(2):209–218.
- Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Petersenn S, Fleseriu M, Casanueva FF, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international consensus statement. Nat Rev Endocrinol. 2023;19(12):722–740.
